Passive immunization through monoclonal antibodies (mAbs) could potentially provide immediate protection against malaria. To guide the development of urgently needed health products, WHO has published preferred product characteristics (PPCs) for mAbs in malaria prevention. These PPCs aim to reduce morbidity and mortality in infants and children due to Plasmodium falciparum, and highlight the preferred characteristics and clinical development considerations for mAbs in this area. This is an exciting development alongside the development of new malaria vaccines and chemoprevention drugs.
🌟 Embracing technology for elderly care is essential in enhancing health and independence. Discover how smart home technologies, wearable devices, and telehealth services are shifting elderly care. Let’s create a supportive environment for our ageing population.
#SyenzaNews #ElderlyCare #AIInHealthcare #HealthTech #Telehealth #WearableTech #SmartHome 🌐
Learn more about the latest innovations in elderly care and how they can improve the quality of life for older adults.
🌍📈 The elderly population in Sub-Saharan Africa is set to triple by 2050, presenting unique healthcare challenges. Our latest article explores the current policy environment, healthcare needs, and future directions for effective policymaking. Let’s ensure our ageing population receives the care and support they deserve. Read more on our website! #SyenzaNews #Healthcare #AgingPopulation #SubSaharanAfrica #PolicyResearch 🌟
🔍 Explore the latest insights on dementia risk factors in the UK! Unveiling trends, disparities, and strategies for effective prevention. Let’s work towards a healthier future together!
#SyenzaNews #HealthcareUK #DementiaResearch #PreventDementia #ResearchInsights 🧠
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
